Zhong Xu
Fujian Medical University(CN)Wuhan University(CN)First Affiliated Hospital of Xiamen University(CN)Hubei Provincial Center for Disease Control and Prevention(CN)Zhongnan Hospital of Wuhan University(CN)The Affiliated Yongchuan Hospital of Chongqing Medical University(CN)Beijing Hospital of Traditional Chinese Medicine(CN)Guizhou Provincial People's Hospital(CN)Chongqing Medical University(CN)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies, Hepatocellular Carcinoma Treatment and Prognosis, RNA modifications and cancer, Parkinson's Disease Mechanisms and Treatments
Most-Cited Works
- → Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice(2017)184 cited
- → Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice(2018)115 cited
- → Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans(2016)103 cited
- → The mTORC2‐Akt1 Cascade Is Crucial for c‐Myc to Promote Hepatocarcinogenesis in Mice and Humans(2019)99 cited
- → Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans(2016)74 cited
- → Prevalence of restless legs syndrome in Parkinson's disease: a systematic review and meta-analysis of observational studies(2018)73 cited